1-1 of 1
Authors: Ayumu Goto
Journal Article
A Phase I/II Study of XELIRI Plus Bevacizumab as Second‐Line Chemotherapy for Japanese Patients With Metastatic Colorectal Cancer (BIX Study)
The Oncologist, Volume 19, Issue 11, November 2014, Pages 1131–1132, https://doi.org/10.1634/theoncologist.2014-0159
Published: 03 October 2014
